Meta-Analysis
Copyright ©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1248-1257
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1248
Figure 3
Figure 3 Severe adverse events from sofosbuvir/velpatasvir with or without ribavirin. SOF/VEL: Sofosbuvir/velpatasvir; RBV: Ribavirin.